109 related articles for article (PubMed ID: 1801884)
1. Phase II trial of oral carmofur in advanced pancreatic carcinoma.
Kajanti MJ; Pyrhönen SO
Ann Oncol; 1991; 2(10):765-6. PubMed ID: 1801884
[TBL] [Abstract][Full Text] [Related]
2. Oral carmofur in advanced gastrointestinal cancer.
Gröhn P; Heinonen E; Kumpulainen E; Länsimies H; Lantto A; Salmi R; Pyrhönen S; Numminen S
Am J Clin Oncol; 1990 Dec; 13(6):477-9. PubMed ID: 2239802
[TBL] [Abstract][Full Text] [Related]
3. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
4. Oral adjuvant chemotherapy with carmofur (HCFU) for colorectal cancer: five-year follow-up. Tokai HCFU Study Group--third study on colorectal cancer.
Ito K; Yamaguchi A; Miura K; Kato T; Baba S; Matsumoto S; Ishii M; Takagi H
J Surg Oncol; 1996 Oct; 63(2):107-11. PubMed ID: 8888803
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of prolonged continuous infusion of 5-fluorouracil and interferon-alpha in patients with advanced pancreatic cancer. Eastern Cooperative Oncology Group Protocol 3292.
Sparano JA; Lipsitz S; Wadler S; Hansen R; Bushunow PW; Kirkwood J; Flynn PJ; Dutcher JP; Benson AB
Am J Clin Oncol; 1996 Dec; 19(6):546-51. PubMed ID: 8931668
[TBL] [Abstract][Full Text] [Related]
6. Optimal duration of oral adjuvant chemotherapy with Carmofur in the colorectal cancer patients: the Kansai Carmofur Study Group trial III.
Nakamura T; Ohno M; Tabuchi Y; Kamigaki T; Fujii H; Yamagishi H; Kuroda Y;
Int J Oncol; 2001 Aug; 19(2):291-8. PubMed ID: 11445841
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin, cytarabine, caffeine, and continuously infused 5-fluorouracil (PACE) in the treatment of advanced pancreatic carcinoma: a phase II study.
Ahmed S; Vaitkevicius VK; Zalupski MM; Du W; Arlauskas P; Gordon C; Kellogg C; Shields AF
Am J Clin Oncol; 2000 Aug; 23(4):420-4. PubMed ID: 10955876
[TBL] [Abstract][Full Text] [Related]
8. [Phase II study of carmofur (HCFU) fine granules].
Koyama Y
Gan To Kagaku Ryoho; 1982 May; 9(5):906-14. PubMed ID: 7184433
[TBL] [Abstract][Full Text] [Related]
9. [Clinical effect of HCFU therapy of head and neck cancer].
Taketa C
Gan To Kagaku Ryoho; 1986 May; 13(5):1846-50. PubMed ID: 3707146
[TBL] [Abstract][Full Text] [Related]
10. A randomized phase I and II study of short-term infusion of high-dose fluorouracil with or without N-(phosphonacetyl)-L-aspartic acid in patients with advanced pancreatic and colorectal cancers.
Ardalan B; Singh G; Silberman H
J Clin Oncol; 1988 Jun; 6(6):1053-8. PubMed ID: 3373260
[TBL] [Abstract][Full Text] [Related]
11. Phase I study of a new antitumor drug, 1-hexylcarbamoyl-5-fluorouracil (HCFU), administered orally: an HCFU clinical study group report.
Koyama Y; Koyama Y
Cancer Treat Rep; 1980; 64(8-9):861-7. PubMed ID: 7448823
[TBL] [Abstract][Full Text] [Related]
12. Phase I trial of low dose N-phosphonacetyl-L-aspartic acid and high dose 5-fluorouracil administered concomitantly with radiation therapy for unresectable localized adenocarcinoma of the pancreas.
Ardalan B; Ucar A; Reddy R; Livingstone AS; Markoe A; Schwade J; Richman SP; Donofrio K
Cancer; 1994 Oct; 74(7):1869-73. PubMed ID: 8082092
[TBL] [Abstract][Full Text] [Related]
13. [Transfer of carmofur (HCFU) to the serum, bile, pancreatic juice and pancreatic tumor tissue in the cases of peri-pancreatic head cancer].
Akaishi S; Kobari M; Yusa T; Yamanami H; Furukawa T; Matsuno S
Gan To Kagaku Ryoho; 1995 Apr; 22(5):659-64. PubMed ID: 7717718
[TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation of 1-hexylcarbamoyl-5-fluorouracil (HCFU) in hepatocellular carcinoma].
Shiraishi K; Kubo Y; Majima Y; Sato K; Sakemi T; Sakai T; Hirai K; Ninomiya F; Abe M; Tanikawa K
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2348-55. PubMed ID: 6093712
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
16. Definitive chemoradiation therapy with capecitabine in locally advanced pancreatic cancer.
Kim HS; Yi SY; Jun HJ; Lee J; Park SH; Lee JK; Lee KT; Lee KH; Choi DW; Choi SH; Heo JS; Park YS; Lim HY; Kang WK; Park HC; Lim DH; Park JO
Anticancer Drugs; 2010 Jan; 21(1):107-12. PubMed ID: 19829097
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) followed by radiation and 5-fluorouracil in locally advanced pancreatic cancer.
Wagener DJ; van Hoesel QG; Yap SH; Hoogenraad WJ; Wobbes T; Strijk SP
Cancer Chemother Pharmacol; 1989; 25(2):131-4. PubMed ID: 2598399
[TBL] [Abstract][Full Text] [Related]
18. Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma.
Ishii H; Okada S; Tokuuye K; Nose H; Okusaka T; Yoshimori M; Nagahama H; Sumi M; Kagami Y; Ikeda H
Cancer; 1997 Apr; 79(8):1516-20. PubMed ID: 9118032
[TBL] [Abstract][Full Text] [Related]
19. Fluorouracil and high-dose leucovorin in previously untreated patients with advanced adenocarcinoma of the pancreas: results of a phase II trial.
DeCaprio JA; Mayer RJ; Gonin R; Arbuck SG
J Clin Oncol; 1991 Dec; 9(12):2128-33. PubMed ID: 1960554
[TBL] [Abstract][Full Text] [Related]
20. [Clinical effects of carmofur (Mifurol) on advanced and recurrent breast cancer in a cooperative study. Research association for re-evaluation of direct effects of Mifurol on breast cancer].
Kusama M; Tominaga T; Enomoto K; Yoshida M; Koyama H; Sonoo H; Takashima S; Abe R; Nishi T; Yamaguchi S
Gan To Kagaku Ryoho; 1995 Mar; 22(4):467-75. PubMed ID: 7887639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]